Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gene therapy for neurometabolic disorders

Gene therapy for neurometabolic disorders

US Patent 10632213 · Granted Apr 28, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Exon skipping oligomer conjugates for muscular dystrophy2025
Gene therapy for neurodegenerative disorders2025
Modified antisense oligomers for exon inclusion in spinal muscular atrophy2024
Gene therapy for neurodegenerative disorders2024
Gene therapy for neurometabolic disorders2024
Gene therapy for neurometabolic disorders2024
Gene therapy for neurodegenerative disorders2024
Exon skipping oligomer conjugates for muscular dystrophy2023
Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders2023
Exon skipping oligomer conjugates for muscular dystrophy2022
Exon skipping oligomer conjugates for muscular dystrophy2022
Gene therapy for lysosomal storage diseases2022